The largest database of trusted experimental protocols

Clariostar

Manufactured by BMG Labtech
Sourced in Germany, United States, United Kingdom, France, Australia, New Caledonia, Japan, Canada

The CLARIOstar is a high-performance microplate reader developed by BMG LABTECH. It is designed to provide accurate and reliable measurement of fluorescence, luminescence, and absorbance in microplate-based assays. The CLARIOstar is capable of reading 96- and 384-well microplates and offers a wide range of detection modes to support a variety of experimental applications.

Automatically generated - may contain errors

984 protocols using clariostar

1

Evaluating HUVEC Viability on Electrospun Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The viability of HUVECs on electrospun scaffolds was determined using the PrestoBlue kit (Thermo Fisher Scientific). Briefly, the cell-scaffolds were immersed in warm PBS and treated with PrestoBlue medium (PrestoBlue: EGM = 1:9) in an incubator. After 30 min incubation, 100 µl of PrestoBlue medium was added into a black 96 well plate with a clear bottom. The fluorescence of each solution was calculated by using a microplate reader (CLARIO star, BMG Labtech) at 590 nm.
Cell proliferation was assessed after 1, 3, and 5 d culture by using a CyQUANT™ Cell Proliferation Assay Kit (Fisher Scientific). The samples were frozen and thawed three times. 250 µl of Proteinase K in Tris/EDTA solution was then added to each sample. After overnight incubation at 56 • C, 40 µl of digested samples was placed into a black 96 well plate and the same volume of lysis buffer was added into the well plate for 1 h incubation. Finally, GR dye (80 µl) was transferred into each well and protected in dark for 15 min. Fluorescence of the solution was measured with the plate reader (CLARIO star, BMG Labtech) at emission and excitation wavelengths of 480 and 520 nm, respectively.
+ Open protocol
+ Expand
2

Metabolic Activity in Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Metabolic activity was measured in fresh and cryopreserved hepatocytes. Phase I metabolism was measured using commercially available luciferin assays, P450-Glo™ (Promega Corporation, Wisconsin, U.S.), for cytochrome P450 1A1, 1A2, 2B6, 2C9, 3A4, and 3A7 as described previously16
. Luminescence was read directly in a multi-well plate luminometer (CLARIOstar, BMG Labtech, North Carolina, U.S.) and expressed as luminescent counting units (LCU)/min normalized to a million viable cells. Phase II activity was determined by the metabolism of the fluorescent compound resorufin according to a published protocol13
. Resorufin fluorescent signals were quantified by a spectrophotometer (CLARIOstar BMG Labtech, North Carolina, U.S. excitation: 535 ± 25, emission: 581 ± 20). Conjugation efficiency was quantified by measuring the decrease in the fluorescent signal and reported as the percentage of resorufin metabolized.
+ Open protocol
+ Expand
3

Screening Small-Cell Lung Cancer Drug Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
SCLC cell line drug response to TAK-243 (0–1 μmol/L) was assessed using the CellTiter Glo 2.0 assay (Promega, #G9243). Cell-lines were plated using the Thermo Scientific Multidrop Combi Reagent Dispenser (#5840300). Drug was added using the Tecan D300e Digital Dispenser. After 3 days, cell viability was assessed by measuring luminescence using a microplate reader (CLARIOstar, BMG LABTECH).
Drug synergy was assessed using cell-line–specific concentration combinations of TAK-243 (0–2 μmol/L) and C/E (1:1 ratio, range = 0–15 μmol/L) or olaparib (range = 0–500 μmol/L). Cell viability was assessed using the alamarBlue resazurin conversion assay (Thermo Fisher Scientific, #DAL1025) by measuring fluorescence after 6 days using a microplate reader (CLARIOstar, BMG LABTECH) as described in the Supplementary Methods.
+ Open protocol
+ Expand
4

Protein Extraction from Microalgae Biomass

Check if the same lab product or an alternative is used in the 5 most similar protocols
For protein extraction, we used freeze-dried biomass obtained after 14 days of cultivation. Basically, for solubilization, we left 5 mg microalgae powder suspended in 50 μL of 1 M NaOH for 10 min in a water bath at 80 °C. Then, we added 450 μL of distilled water, and the resulting solution was centrifuged for 30 min at 12,000× g (in a Universal 320 R centrifuge, Hettich, Tuttlingen, Germany), and the supernatant was moved to another tube. The above procedure was repeated twice, and the last extract was combined. The protein content was determined using two methods, Bradford and Biuret. For the Bradford method, we used bovine serum albumin (BSA) as standard in a concentration series of 0–10 µg/mL [95 (link)]. Briefly, over 200 µL of a sample, we added 50 µL of Bradford Reagent (Bradford Reagent, Sigma, Merck Group, Darmstadt, Germany), incubated for 5 min, and read the absorbance in a 96 well plate reader (CLARIOStar, BMG Labtech, Ortenberg, Germany) at a wavelength λ of 595 nm. For Biuret, the BSA standard curve was 0–10 mg/mL. Briefly, we added 200 µL of Biuret reagent to 40 µL of the sample; we incubated it in the dark at room temperature for 30 min, and then the absorbance (CLARIOStar, BMG Labtech, Ortenberg, Germany) was read at the wavelength λ = 555 nm.
+ Open protocol
+ Expand
5

Virus Replication Quantification Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
Myxoma virus titers were determined by standard plaque assay on RK13 cells, as described in Camus-Bouclainville et al. (30 (link)). Enterovirus D68 and influenza virus titers were determined by the tissue culture infectious dose 50 (TCID50) method, as described in Soubies et al. (38 (link)). We measured replication of luciferase expressing virus 24 h post-infection by lysing cells and measuring light emission on a Clariostar (BMG Labtech) plate reader using the Luciferase assay System kit (Promega) according to the manufacturer's instructions. We measured replication of TMEV expressing the fluorescent protein Cherry by measuring fluorescence using a Clariostar (BMG Labtech) plate reader. hRSV expressing Cherry was detected in paraformaldehyde fixed HEp-2 cells by immunofluorescence and imaged using a confocal microscope. Replication of hAdV and hCMV expressing AnchOR3 protein was quantified by measuring GFP foci using automated microscopy, as described in Komatsu et al. (27 (link)) and Mariamé et al. (31 (link)).
+ Open protocol
+ Expand
6

Muscarinic Receptor Expression in Flp-In T-REx 293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flp-In T-REx 293 cell lines able to express hM1-mEGFP were grown to 100,000 cells/well in 96-well solid black bottom plates (Greiner Bio-One) precoated with 0.1 mg·ml−1 poly-d-lysine. Cells were treated with 100 ng·ml−1 doxycycline to induce the expression of hM1-mEGFP. After 24-h induction, cells were washed three times in Hanks' balanced salt solution buffer. 100 μl of Hanks' balanced salt solution was added to each well, and the plates were read using a CLARIOstar fluorescence plate reader (BMG Labtechnologies). Specifically, cells were excited at 462 nm, and the emission spectrum between 500 and 600 nm was collected at 5-nm intervals. The same process was repeated after the addition to each well of 100 μl of Hanks' balanced salt solution supplemented with the vehicle or the appropriate muscarinic receptor antagonist.
+ Open protocol
+ Expand
7

HCV Neutralization Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCV neutralization assays were performed as described.[28] Briefly, HEK293T cells were cotransfected in a 1:1 (w/w) ratio of pE1E2H77c (gt‐1a; Genbank AF011751) or pUKN3A1.9 (gt‐3a; Genbank AY734985) and pNL4–3.LUC.R‐E‐ to produce HCVpp. Alternatively, infectious HCV cell culture (HCVcc)‐derived genotype 3a (S52; Genbank EU204645), and 5a (SA13; Genbank FJ393024) were produced by transfecting Huh7.5 cells with in vitro–transcribed RNA by electroporation,[26] with the modification that luciferase activity was measured in a microplate reader (ClarioSTAR; BMG Labtechnologies). Mean percentage entry was calculated as (relative light units [RLU] plasma + virus)/(RLU medium+virus) × 100. Percentage entry was plotted against the reciprocal dilution of plasma in GraphPad Prism software (version 9; GraphPad Software) and curves fitted with a one‐site specific binding Hill plot. The reciprocal dilution of plasma required to prevent 50% virus entry was calculated from the nonlinear regression line (ID50). The lowest amount of nAb detectable was a titer of 40. Samples that did not reach 50% neutralization were assigned an arbitrary value of 20.
+ Open protocol
+ Expand
8

HCV Neutralization Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCV neutralization assays were performed as described previously (53 (link)). Briefly, HEK293T cells were co-transfected in a 1:1 (w/w) ratio of pE1E2H77c and pNL4–3.LUC.R-E- to produce HCV H77pp (54 (link), 55 (link)). 1:40 dilutions of guinea pig sera were added to H77pp and incubated for 1 h at 37 °C before addition to Huh7.5 cells. After incubation for 4 h, the inocula were removed, and cells were incubated in fresh media for 72 h. Following lysis in cell culture lysis buffer (Promega, Madison WI), luciferase activity in clarified lysates was measured by using a luciferase substrate (Promega) on a CLARIOstar microplate reader fitted with luminescence optics (BMG Lab Technologies). Infectious cell culture–derived genotype 2a (J6), 3a (S52), and 5a (SA13) HCVcc were produced by transfecting Huh7.5s with in vitro–transcribed RNA by electroporation as described previously (25 (link)). NAb assays were performed by mixing HCVcc with 1:40 dilutions of guinea pig sera as described above with incubation for 42 h after removal of the inocula. Luciferase activity in cell lysates was measured using Renilla luciferase substrate (Promega).
+ Open protocol
+ Expand
9

Hypoxia-induced Glucose Uptake Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hypoxia-treated A549 and H1975 cells were starved in 0.1% glucose-free RPMI containing 0.1% FBS for 16 h. Then, to these cells was added 2-(N-[7-nitrobenz-2-oxa-1,3-diazol-4-yl] amino)-2-deoxy-d-glucose (5 μM) for 30 min, and the fluorescence intensity was read using a microplate reader (Clario Star; BMG Labtech, Ortenberg, Germany). The concentration of lactate was measured using lactate assay kit II (Invitrogen) before collection of the cell extract of hypoxic A549 and H1975 cells.
+ Open protocol
+ Expand
10

BLM-HD Phosphate Detection Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Assay uses the PiColorLock Gold Phosphate Detection System from Novus Biologicals following the manufacturer’s recommended protocol. Briefly, assays were carried out in 96-well clear flat-bottomed plates, with absorbance measurements taken at a wavelength of 630 nm in a CLARIOstar multimode plate reader (BMG Labtech). Assay buffer: 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 2 mM MgCl2, 0.05% v/v Tween-20, 0.5 mM TCEP.
165 μl of BLM-HD and ssDNA-20mer (at a concentration of 2.4 nM and 121 nM, respectively) was pre-incubated with 10 μl of compound (2 mM stock dissolved in 100 % v/v DMSO, over a range of final concentrations up to 100 µM) for a period of 15 min at room temperature. Next, 25 µl of Mg-ATP substrate (at 16 mM) was added. After 20 min, reactions were stopped by the addition of 50 μl Gold mix (a 100:1 ratio of PiColorLock:Accelerator reagents). After 2 min, 20 μl of stabiliser solution was added to each well. After a further 30 min absorbance measurements were taken.
Assay conditions: 2 nM BLM-HD, 100 nM ssDNA-20mer and 2 mM Mg-ATP in a reaction volume of 200 µl over a 20-min incubation period.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!